BRAF and metastatic malignant neoplasm in the lymph nodes: They performed molecular testing on tumors from pN1b patients (those with at least one significant lymph node metastasis) and pN0 patients (those with at least five histologically normal lymph nodes) and found that approximately 61% of the samples tested had the BRAF mutation, mostly BRAF V600E (except for two samples).